共 50 条
- [2] Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells [J]. Scientific Reports, 10
- [6] Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells [J]. British Journal of Cancer, 2014, 110 : 2865 - 2873
- [10] Targeting triple-negative breast cancer [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21